Clinical trial
Assessment of Tumor Resistance and Stem Cells in Prostate Cancer
NCT00991315 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Tumor Resistance and Stem Cells in Prostate Cancer
- Lead sponsor
- Rutgers, The State University of New Jersey
- Phase
- Observational
- Overall status
- Terminated
- Start date
- December 12, 2008
- Completion date
- April 10, 2017
- Enrollment
- 126 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer